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Abstract: Redox biology is still looking for tools to monitor redox potential in cellular biology and,
despite a large and sustained effort, reliable molecular probes have yet to emerge. In contrast,
molecular probes for reactive oxygen and nitrogen have been widely explored. In this manuscript,
three kinetically inert lanthanide complexes that selectively react with hypochlorous acid are prepared
and characterized. The design is based on 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A)
and 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (DO2A) ligands appended with one or two redox
active hydroquinone derived arms, thereby forming octadentate ligands ideally suited to complex
trivalent lanthanide ions. The three complexes are found to react selectively with hypochlorous
acid to form highly symmetric lanthanide(III) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacedic
acid (DOTA) complexes. The conversion of the probe to [Ln.DOTA]− is followed by luminescence,
absorption, and NMR spectroscopy in a model system comprised of a Triton-X modified HEPES buffer.
It was concluded that the design principle works, and that simple caging units like hydroquinones
can work well in conjugation with lanthanide(III) complexes.
Keywords: lanthanide coordination chemistry; lanthanide luminescence; responsive molecular
probes; ROS probes; reactive oxygen species
1. Introduction
Reactive Oxygen Species (ROS), and Reactive Nitrogen Species (RNS) [1–3], are classes of
compounds that include one- or two-electrons oxidants and play essential roles in living organisms [1,2].
The most relevant ROS originate from a cascade started by the one electron reduction of O2 giving the
superoxide radical (O2−) by means of either NADPH oxidases (NOXs) or by leakage in the electron
transport chain inside the mitochondria [1,3–8]. Superoxide Dismutase (SOD) is responsible for
the conversion of superoxide into hydrogen peroxide (H2O2) which, in turn, can either undergo a
Fenton reaction in the presence of Fe2+ (or Cu2+) to give the hydroxyl radical OH· or convert to
hypochlorous acid by action of Myeloperoxidase (MPO). ROS play numerous and diverse roles in
biology: Biomolecules are responsive to redox conditions and many biological processes are regulated
by redox chemistry [1,2,6,7]; although the first understanding of ROS concerned either their deleterious
action against lipids, proteins and nucleic acids or their role as antimicrobial agents, the importance
of these reactive molecules has recently been revised, spurring the need for better probes to detect
them [4,9,10]. Given the key role of ROS in biology, many methods have been developed in order
to detect them. Among these, mass spectrometry and a plethora of fluorescent and luminescent
probes have been proposed over the years [4,11–14]; these probes have also been conjugated to
units (peptides or TTP) that can target specific organelles [4]; however, because of the complexity of
both living organisms and redox processes in vivo, the selective and reliable detection of ROS has
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proved tricky [9,15,16]. Here, we consider luminescent probes for ROS detection that are based on
lanthanide(III) luminescence [9,17].
Lanthanide ions possess unique luminescence properties [18]: Lanthanide(III) ions gives rise to
high sensitivity even at low concentrations [19], have sharp and characteristic emission bands, and long
luminescent lifetimes in the order of µs-ms [18,20]. The excited states of lanthanide(III) ions are not
quenched by O2 and the distinctive and sharp bands boost both signal to noise ratio and sensitivity
to analytes. Additionally, DOTA-like lanthanide(III) complexes are fully water soluble, non-toxic
and inert in physiological conditions [21]. In a typical probe design, the Ln3+ ion is coordinated to a
chelator to avoid release of the toxic free ion in the media and to confer the desired features [18,22,23].
Macrocycles like DOTA and its derivatives are more rigid and can form complexes with higher kinetic
inertness than open chain chelators [22,24]. Thanks to the kinetic inertness, these complexes can be seen
as molecular building blocks and can be linked to different units [23]. The sensing of an analyte can
arise from either direct coordination of the analyte to the lanthanide ion centre or from binding/reaction
of the analyte with a responsive unit on the chelator. Lanthanide-based probes have been developed
to detect an array of analytes [25], e.g., metal ions [26–28], anions [29], ATP [30–34], ROS [13,35,36],
and pH [37,38].
The majority of molecular probes for Reactive Oxygen and Nitrogen Species (RONS) are based on
organic dyes, although some examples of lanthanide(III)-based probes have been reported [11,39–43].
Most probes are based on a cage on/off mechanisms: the cage acts as a leaving group upon reaction
with the RONS, and in the lanthanide(III)-based probes, the cage blocks the energy transfer from an
antenna to the lanthanide centre. When the cage reacts with the RONS, it is cleaved and the antenna is
free to transfer energy to the lanthanide(III) centre [44]. Examples of caging units are pinacol boronic
esters [36,45], p-aminophenoxy groups [13,46], and dinitrophenyl groups [47], and probes based on
these are reported as selective for H2O2 and hROS (Highly Reactive Oxygen Species, HOCl and ·OH).
Borbas et al. developed a versatile platform built around the deprotection of a coumarin, thus unlocking
its sensitization activity towards Eu3+ [45]. Another approach to the design of responsive complexes
is the in situ formation of an antenna upon reaction with the ROS. Pierre et al. developed a library
of pre-antennas based on aromatic acids or amides; these are hydroxilated in the presence of ·OH
and coordinate to a Tb.DO3A complex, thus enhancing the luminescence intensity [48]. Finally,
a ferrocene appended Eu.DO3A complex prepared by Faulkner should be mentioned. This probe
reversibly responds to redox processes [49]. The relevance of this probe is that, unlike the ones reported
here, it does not depend on an irreversible process. The advantage of a reversible detection is that
saturation of the probe is avoided and a continuous monitoring of the system’s redox state would be
feasible [9,50,51].
In this work, we also adopt a design based on a cage, although exploiting a different mode of
action. The complexes shown in Figure 1 all carry a hydroquinone cage that is released upon reaction
with hypochlorous acid forming quinone and the same fully symmetrical [Ln.DOTA]− complex,
see Scheme 1, a transformation that can be followed using luminescence, absorption, and NMR
spectroscopy. The results presented here validate the design concept, and further show that the
incorporation of the caging group in a lanthanide(III) complex significantly reduces the reactivity.
Finally, it should be noted that the complexes explored here, does not incorporate an antenna
chromophore. While this does not constitute an issue in our experiments, it limits the applicability of
the complexes studied as molecular probes.
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2. Results and Discussion
We designed and sy thesized three different ligands and prepared their europium(III) and
terbium(III) complexes. Considering the three lanthanide(III) complexes Ln.L1 and Ln.L2 are inherently
different from Ln.L3 as the former two are based on the 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic
acid (DO3A) scaffold, while the latter is a 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (DO2A)
derivative. The symmetry of the complexes is different, which is expected to be reflected in both NMR
and luminescence spectra. Finally, neither of the complexes contains a chromophore, which infers that
the relatively inefficient direct excitation into the lanthanide(III) excited state manifold is required if
these complexes are to be used as molecular probes.
Considering the three complexes as reactive probes for RONS, there are clear differences that are
probed by using these structures. Where Ln.L1 and Ln.L3 both carry mono-esters of hydroquinone,
one and two respectively, Ln.L2 has two lanthanide binding pockets on a di-ester of hydroquinone.
Please note that both Ln.L2 and Ln.L3 are converted to Ln.L1 upon the first reaction with RONS,
see Scheme 1. Thus, the reactivity of the two hydroquinone esters can be compared, and it can be
concluded if the incorporation of subsequent un-caging is a viable route towards higher selectivity.
To perform these comparisons, a reliable testbed for the reaction between RONS and the lanthanide(III)
complexes was required.
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2.1. Oxidation Testbed
To investigate the reaction between RONS and various probes, we tested several solvent and
buffer systems. We tested using hydroquinone and the naturally occurring antioxidant α-tocopherol in
order to simulate the different solubilities and reactivities of various probes. We selected to work at
neutral pH as the end target is probes for molecular biology. Figure 2 shows the results obtained in our
optimized buffer system which consists of 100 mM HEPES buffer with 1–3% Triton X-100 depending
on the lipophilicity of the probes investigated. These conditions provide beautiful absorption spectra,
where the oxidation of hydroquinone andα-tocopherol can be followed. Please note that full conversion
is achieved when 1.5–2.0 equivalents of hypochlorous acid have been added.
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Figure 2. Oxidation test bed performance. (a) Absorption spectra of hydroquinone upon addition of
hypochlorous acid. (b) Plot of the absorbance at 245 nm versus equivalents of added hypochlorous acid
for hydroquinone oxidation. (c) Absorption spectra ofα-tocopherol upon addition of hypochlorous acid.
(d) Plot of the absorbance at 263 nm versus equivalents of added hypochlorous acid for α-tocopherol
oxidation. (e) Molecular structures of HEPES and Triton X-100.
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2.2. Synthesis
The target molecules, shown in Figure 1, are made from the four building blocks shown in Figure 3.
The pendant arms 1 and 3 are obtained via nucleophilic substitution reactions between chloroacetyl
chloride and hydroquinone in high yields as white crystals and ice white flakes, respectively (Scheme 2).
Protection of the phenol unit in 1 is carried out with tert-butyldimethylsilyl chloride and N-methyl
imidazole in DMF to give the protected pendant arm 2 as a colourless oil in 64% yield after purification.
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Scheme 2. Reaction leading to compounds 1, 2 and 3.
Protected ligands 4 and 5 are synthesized by linking the pendant arms 2 and 3, respectively, to the
DO3A-triester via nucleophilic substitution. For 4, stirring in MeCN with NaHCO3 for 26 h gives
the desired compound as a transparent oil in moderate yields (55–60% over 4 runs of the reaction).
Compound 5 is obtained in 52% yield as a yellow viscous oil in similar conditions under reflux and
with DIPEA as base, see Scheme 3.
For the preparation of protected ligand 9, the reported procedure [52], as seen in Scheme 4,
first requires the formation of the regioselectively disubstituted cyclen with the carboxylbenzyl group.
The synthesis is carried out with benzyl chloroformate at 60 ◦C in chloroform for 100 min, giving the
disubstituted compound as a colourless oil in 57% yield after work up. The introduction of tert-butyl
acetate groups is conducted in refluxing acetonitrile with DIPEA for 30 min in excellent yield, giving 7
as a pale yellow oil. The removal of the carboxylbenzyl groups is achieved by microwave irradiation
in isopropanol catalyzed by Pd/C with ammonium formate as source of hydrogen, yielding compound
8 as a white solid (98%). The resulting DO2A-diester is reacted with the pendant arm 2 and DIPEA in
refluxing acetonitrile for 2 h, giving the protected ligand 9 as a pale yellow oil in reasonable yields
after purification by column chromatography (50–55% after 2 runs of the reaction).
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The deprotection of both the tert-butyldimethylsilyl and tert-butyl groups is obtained by stirring
the protected ligand with TFA in DCM at room temperature. The desired compound is retrieved
after multiple triturations from MeOH and diethyl ether to remove excess TFA. Scheme 5 shows the
reaction for the formation of ligand L1, obtained as a white solid in 39% yield. L2 is attained in the
same conditions and in comparable yields to L1 as an off white solid (32%). In the case of L3, 72 h are
required to get acceptable yields (36%) and give the desired ligand as an off-white powder.
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Scheme 5. Deprotection of 4 leading to the DOTA-monoester ligand L1.
The lanthanide (III) complexes of Eu (III) and Tb (III) with L1, L2 and L3 are obtained as white
powders by reacting the ligand with either 1 equivalent (L1 and L3) or 2 equivalents (L2) of the
lanthanide (III) triflate salt in MeOH at 60 ◦C for 72 h.
2.3. Characterisation
The synthesized ligands and complexes were characterized using mass spectrometry and NMR.
The 1H NMR spectra of the three europium(III) complexes Eu.L1, Eu.L2 and Eu.L3 are shown in Figure 4
and contrasted to the spectrum of [Eu.DOTA]−. Eu.L1 has no symmetry and resonances from the
four axial protons are observed, whereas only a single resonance is seen in the DOTA complex. Eu.L2
and Eu.L3 are both C2 symmetric and a much simpler 1H NMR spectrum is observed. Eu.L3 shows a
spectrum very similar to the C4 symmetric DOTA complex. So does Eu.L2, but here the symmetry is
broken in a fraction of the population, possibly by association to a capping ligand [53]. Please note that
all complexes in Figure 4 are predominately in the SAP conformation.
The 1H NMR spectra indicate a DOTA like structure of all complexes, with added conformational
freedom in Eu.L2. This is confirmed by the luminescence emission spectra, where the emission
spectrum of Eu.L2 is more similar to that of DO3A than DOTA [53]. In contrast, the emission spectra of
Eu.L1 and Eu.L3 are both structured, and the band at 590 nm corresponding to the 5D0→7F1 transition
shows the different symmetry of the two complexes. Three lines are resolved for the asymmetric Eu.L1,
and two lines are seen in the symmetric Eu.L3. The luminescence spectra are included in Figure 5.
Time-gating did not provide any benefits in the model system and only steady-state spectra are used in
this study.
Molecules 2020, 25, 1959 8 of 23
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green), Eu.L2 (third, red) and Eu.L2 (bottom, purple).
The last panels in Figure 5 show the steady-state and time-gated emission spectrum of Tb.L1.
Excitation in the absorption band of the hydroquinone unit clearly gives rise to terbium(III) centred
emission, with appreciable efficiency. Thus, the terbium(III) complexes can be used as intensity-based
probes, as oxidation will lead to loss of the hydroquinone unit which is followed by a significant loss
of emission intensity. The caveat for using this mode of operation is that it requires excitation in the
deep UV. The excitation spectrum in Figure 5b shows that direct excitation of europium(III) is more
efficient than the antenna-mediated excitation, and this will not be considered further. All excitation
and emission spectra are available as Supplementary Materials.
The luminescent lifetimes of the complexes were determined using an exponential fit to the
time-resolved emission decay profiles. The results are compiled in Table 1, and show clear differences
between the complexes. In Tb.L2 and Tb.L3 the terbium excited state lifetime is reduced by ligand
specific quenching pathways that are absent in Tb.L1. Similarly, the luminescent lifetime of Eu.L1 also
resembles those observed from other DO3A complexes [53], while those observed in Eu.L2 and Eu.L3
are significantly reduced. This suggest additional quenching pathways operate in Ln.L2 and Ln.L3,
both redox mediated charge transfer and back energy transfer to the antenna centred triplet state
are viable explanations. As the luminescence intensity is important for an efficient molecular probe,
Molecules 2020, 25, 1959 9 of 23
further developments should exploit the Ln.L1 scaffold as—based on the luminescence lifetime—this
is the most promising candidate of the three.Molecules 2020, 25, x FOR PEER REVIEW 9 of 23 
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Table 1. Luminescent lifetimes (ms) of the europium(III) and terbium(III) complexes determined in the
relevant medium and D2O.
Compound 0.1 M HEPES pH 7.2 D2O 1
Eu.L1 0.524 1.391
Eu.L2 0.086 (17%)/0.546 (83%) 0.792
Eu.L3 0.259 0.917
Tb.L1 1.273 1.931
Tb.L2 0.420 0.776
Tb.L3 0.366 0.929
1 As the conditions are widely different the number of inner sphere solvent molecules (q) [54–56] was not calculated.
2.4. Response to Reactive Oxygen Species
The response of Eu.L1, Eu.L2, and Eu.L3 towards ROS were studied in detail, and the response of
Tb.L1, Tb.L2, and Tb.L3 when exposed to hypochlorous acid was investigated. The complexes were
dissolved in 0.1 mM HEPES buffer without Triton X-100 as all complexes are fully soluble. H2O2 or
HClO were added and after 5 min the spectra were recorded. No reaction was observed with hydrogen
peroxide, and we concluded that the complexes are selective for hypochlorous acid.
The response of all six complexes are due to the oxidation of hydroquinone to quinone, and a
subsequent hydrolysis of the Ln.DOTA-ester to [Ln.DOTA]−. The transformation is shown for Eu.L1
in Scheme 1. For Ln.L2 and Ln.L3 the first oxidation/hydrolysis step leads to the formation of Ln.L1,
which then upon a second oxidation is converted to [Ln.DOTA]−. Figure 6 shows the spectra of Eu.L1
when 1–25 equivalents of HOCl have been added. There is a small observable change in intensity,
but the most significant change is in the band at 590 nm arising from the 5D0→7F1 transition. In this
band-consisting of three lines-the ligand field can be probed via the three microstates in 7F1. In Eu.L1,
a DO3A system, the three microstates are all resolved, while in the product there are two degenerate
microstates. The product spectrum is very similar to that of [Eu.DOTA]−, and that the product is
indeed [Eu.DOTA]−, can be seen from the series of 1H NMR spectra shown in Figure 7. This is further
supported by the direct comparison of the Eu.L1 oxidation product luminescence emission spectrum
to that of [Eu.DOTA]−, see Figure 8a. Thus, the mechanism of the response is confirmed.
The response of the probes can be determined in several ways. Figure 6 shows the ratiometric
change in the emission spectrum as the symmetry of the complexes change, which can be converted
into a response function by comparing the intensity at two emission wavelengths as done in Figure 8b.
Figure 8c shows how the intensity of antenna mediated europium(III) luminescence decreases as
the caging group is hydrolysed, and Figure 8d shows the corresponding response function. Finally,
Figure 8e,f shows how the overall intensity increase of the Ln.L3 luminescence can be used as a
response. The change in spectral shape can be used for europium(III) only. The intensity response
works equally well for europium(III) and terbium(III) complexes.
Figure 8 includes the response function of the three probes as a function of equivalents of HOCl
added. Compared to the response function of the free hydroquinone, a significant excess of oxidant is
needed to achieve full conversion of the probes. For all three complexes an excess of 15 equivalents of
HOCl is needed, which indicates that the lanthanide complex significantly reduces the reactivity of
the hydroquinone ester. Please note that the mono-esters of hydroquinone in Ln.L1 and Ln.L3 show
similar reactivity as the di-ester of hydroquinone in Ln.L2, although full conversion is reached at
30 equivalents for Ln.L2 and 15–25 equivalents with the mono-esters. Furthermore, the two reactions
that are required for full conversion of Ln.L2 and Ln.L3 are not reflected in the number of equivalents
needed for full conversion. Thus, we conclude that the reactivity of the hydroquinone esters is dictated
by the structure of the lanthanide complex, rather than the hydroquinone esters themselves. This is
supported by the fact that the reaction of the model systems, see Figure 2, proceed with full conversion
by addition of the expected two equivalents of hROS.
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3. Materials and Methods
3.1. General
All solvents and chemicals were purchased from Sigma-Aldrich, TCI chemicals, Acros Organics,
Alfa Aesar, Fluka, Merck, Abcr or VWR chemicals. The solvents were HPLC or technical grade.
Demineralized H2O was used. THF was distilled over Na/benzophenone. DMF, DCM and Toluene
were dried over activated molecular sieves (4A). Inert atmosphere for reactions was obtained by either
maintaining a constant argon flow from a balloon filled with argon and connected through a syringe
needle in a septum or from constant flow of nitrogen through a bubbler. All synthesized compounds
containing air-sensitive units were stored under inert gas in small vials for a maximum of 5 weeks
and, after that time, their condition was checked before use. Column chromatography was performed
on silica gel pore size 60 Å, particle size 40–63 µm, 239–400 mesh from Rocc. Silica gel plates 60 F254
from Merck were used for thin layer chromatography. 1H-NMR and 13C-NMR spectra were recorded
on a Bruker 500 MHz and 126 MHz respectively. All chemical shifts (δ) are expressed in parts per
million (ppm). The deuterated solvents were used as internal references with the reported values
(CDCl3 δH 7.26 δC 77.16, CD3OD δH 3.31 δC 49.00, D2O δH 4.79). ESI+-MS spectra were recorded on a
Bruker Solarix FTICR instrument. MALDI-TOF spectra were recorded on a Bruker Speed Autoflex with
dithranol as matrix. GC-MS traces and spectra were recorded on an Agilent 6890 Series (GC system)
and Agilent 5973 Mass Selective Detector with tert-butylmethyl ether as solvent for injections. Melting
points are uncorrected and measured on a Stuart SMP30 instrument. All aqueous solutions were
prepared in demineralized water. The pH for buffer solutions was measured with a Mettler-Toledo
Seven Easy pH meter. HEPES buffer 0.1 M was prepared from 2.383 g of purchased HEPES in 100 mL
of demineralized H2O. PBS buffer 20 and 40 mM was prepared from diluting purchased PBS buffer
100 mM. Aqueous solution of HOCl 5% w/v was prepared from 384 mg of purchased Ca(OCl)2 (65%
available chlorine) in 5 mL of demineralized H2O. Deuterated DOCl 5% w/v solution was prepared
from 38.4 mg Ca(OCl)2, 65% available chlorine, in 0.5 mL D2O. H2O2 30% w/v was used as purchased.
H2O2 3% w/v was prepared from dilution of the purchased H2O2 30% w/v. A solution of Horseradish
Peroxidase 750 U/mL was prepared from 1.41 mg of Horseradish Peroxidase (E.C. 1.11.1.7, 150 U/mg)
in 0.282 mL PBS 40 mM at pH 6.5.
Absorption spectra were recorded on a Cary 300 UV-Vis Spectrophotometer at room temperature
and using pure solvent as baseline. The slits were set at 2 nm, the integration time was 0.1 s and the step
size was 1 nm. Excitation spectra were acquired on a HORIBA PTI QuantaMaster 8075–22 instrument
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with a Steady State Xenon Arc lamp. The excitation slits were set at 2 nm and the emission slits at
7 nm, the integration time was 0.15 s and the step 1 nm for all experiments unless stated otherwise.
The spectra were recorded at 25 ◦C. The excitation and emission wavelengths are reported on the
spectra. The uncorrected spectra were used for qualitative individuation of peaks. Emission spectra
were acquired on a HORIBA PTI Quanta Master 8075–22 instrument with a Steady State Xenon Arc
lamp. The excitation slits were set at 8 nm and the emission slits at 2 nm, the integration time was
0.1 s and the step 1 nm for all experiments unless stated otherwise. The spectra were recorded at
25 ◦C. The excitation and emission wavelengths are reported on the spectra. The reported spectra
were corrected with the correction file provided with the software. Time-gated emission spectra were
acquired on a Cary Eclipse fluorescence spectrometer in phosphorescence mode. The delay time was
0.15 ms with a gate time of 5 ms. The excitation slits were set to 10 nm and the emission slits to 5 nm or
2.5 nm. Lifetime measurements were obtained on a HORIBA PTI QuantaMaster 8075–22 instrument
with a Flash Xenon lamp. The excitation slits were set at 8 nm and the emission slits at 8 nm, the start
time was 300 µs and end time 10,000 µs. The spectra were recorded at 25 ◦C. The excitation and
emission wavelengths are reported on the spectra. The data was fitted using OriginPro 2017.Starna
Scientific 10 mm quartz cuvettes were employed for all samples at room temperature.
3.2. Synthetic Procedures
3.2.1. Synthesis of 4-Hydroxyphenyl 2-chloroacetate (1)
Hydroquinone (1.00 g, 9.08 mmol) was dissolved in DMF (18.1 mL). Chloroacetyl chloride
(0.866 mL, 10.9 mmol) was added dropwise under a positive nitrogen atmosphere over 10 min and the
clear solution soon became pale yellow. After 45 min the reaction was quenched by addition of 20 mL
H2O and the white precipitated diester was filtered off. The filtrate was extracted with Et2O (20 mL × 3).
The combined organic layers were washed with H2O (30 mL × 2) and brine, dried over MgSO4 and
concentrated in vacuo to yield the crude compound 1 as a white powder. The crude was recrystallized
in H2O and pure compound 1 was obtained as white crystals (1.44 g, 7.72 mmol, 85%). 1H-NMR
(500 MHz, CDCl3): δ 6.99 (d, Har, 2H), 6.84 (d, Har, 2H), 4.28 (s, Cl-CH2-CO, 2H) 13C-NMR (300 MHz,
CDCl3): δ 153.75 (C4) 122.29 (Car), 116.21 (Car), 41.01 (Cl-C-CO) ESI+-MS: C8H7ClO3 [M + Na]+ m/zcalc
208.99759 m/zfound 208.99778 λabs (HEPES 0.1 M, pH 7.2) = 275 nm, 221 nm.
3.2.2. Synthesis of 4-((Tert-butyldimethylsilyl)oxy)phenyl 2-chloroacetate (2)
TBDMSCl (400 mg, 2.14 mmol) was dissolved in DMF (4.2 mL) and N-Methyl Imidazole (0.64 mL,
8.04 mmol) was slowly added under a positive nitrogen atmosphere. The mixture was allowed to
stir for a few minutes and then a solution of 1 (500 mg, 2.68 mmol) in DMF (1.9 mL) was introduced.
The solution was stirred at room temperature for 4 h and then quenched by addition of H2O (10 mL).
The mixture was extracted with Et2O (15 mL × 3) and the combined organic layers were washed with
H2O (20 mL × 3) and brine. After drying over MgSO4, the solvent was evaporated under reduced
pressure to yield a colourless oil. The crude product was purified by column chromatography (8:2
Petroleum Ether: EtOAc) and dried for a day on the oil pump to yield the pure compound 2 as a
colourless oil (516 mg, 1.72 mmol, 64%). 1H-NMR (500 MHz, CDCl3): δ 6.99 (d, Har, 2H), 6.83 (d,
Har, 2H), 4.27 (s, Cl-CH2-CO, 2H), 0.98 (s, Si-C-CH3, 9H), 0.19 (s, Si-CH3, 6H) 13C-NMR (300 MHz,
CDCl3): δ 166.21 (CO), 153.85 (C4), 121.95 (Car), 120.79 (Car), 41.05 (Cl-C-CO), 25.78 (Si-C-(CH3)3), 18.32
(Si-C-(CH3)3, −4.32 (Si-CH3) ESI+-MS: C14H21ClO3Si [M + H]+ m/zcalc 301.10213 m/zfound 301.10223.
3.2.3. Synthesis of 1,4-Phenylene bis(2-chloroacetate) (3)
Hydroquinone (1.00 g, 9.08 mmol) and imidazole (1.36 g, 19.98 mmol) were dissolved in DMF
(18.2 mL). Chloroacetyl chloride (1.59 mL, 19.98 mmol) was added dropwise over 5 min under a
positive argon atmosphere and the mixture was left stirring overnight at room temperature. The colour
of the solution changed from colourless to bright yellow. H2O (25 mL) was added to quench the
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reaction and a part of compound 3 precipitated as a white powder. This was filtered off and repeatedly
washed with H2O. The filtrate was then extracted with DCM (15 mL × 3), the organic layers were
washed with H2O (15 mL × 2) and brine. After drying over MgSO4, the solvent was evaporated to
yield a white powder. The residue was dissolved in the minimum amount of EtOH and triturated
with H2O to yield pure compound 3 (2.21 g, 8.36 mmol, 92%) as ice white flakes. 1H-NMR (500 MHz,
CDCl3): δ 7.18 (s, Har, 4H), 4.30 (s, Cl-CH2-CO, 4H) 13C-NMR (300 MHz, CDCl3): δ 122.41 (Car), 40.93
(Cl-C-CO) ESI+-MS: C10H8Cl2O4 [M + Na]+ m/zcalc 284.96919 m/zfound 284.96962.
3.2.4. Synthesis of Tri-tert-butyl
2,2′,2′′-(10-(2-(4-((tert-butyldimethylsilyl)oxy)phenoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-
1,4,7-triyl)triacetate (4)
The tert-Butyl triester of DO3A (280 mg, 0.54 mmol) was dissolved in MeCN (4.5 mL) and NaHCO3
(91 g, 1.09 mmol) was added. Compound 2 (196 mg, 0.65 mmol) was dissolved in MeCN (0.9 mL) and
added to the solution.
The reaction was followed with MALDI-TOF (matrix: dithranol) and the mixture was stirred at
room temperature for 26 h under argon. After this time, the solution was diluted with H2O (10 mL)
and extracted with DCM (5 mL × 3). The combined organic layers were washed with H2O (5 mL
× 3) and brine. After drying over MgSO4, the solvent was evaporated and the crude product was
purified by column chromatography (9.5–9: 0.5–1 DCM: MeOH) to yield product 4 as a colourless
oil. (247 mg, 0.31 mmol, 58%). 1H-NMR (500 MHz, CDCl3): δ 6.93 (d, Har, 2H), 6.81 (d, Har, 2H),
4.17–2.62 (m-bs, Hring+ N-CH2-CO, 24H), 1.45 (s, Ot-Bu, 27H), 0.98 (s, Si-C-CH3, 9H), 0.19 (s, Si-CH3, 6H)
13C-NMR (300 MHz, CDCl3): δ 122.17 (Car), 120.75 (Car), 56.26, 28.24, 25.80,−4.31 (Si-CH3) ESI+-MS:
C40H70N4O9Si [M + H]+ m/zcalc 779.49848 m/zfound 779.50212.
3.2.5. Synthesis of Hexa-tert-butyl 2,2′,2′′-(10-(1,4-phenylene)
bis-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)acetate (5)
The tert-Butyl triester of DO3A (645 mg, 1.25 mmol) was dissolved in MeCN (4 mL) and DIPEA
(0.43 mL, 2.51 mmol) was added dropwise. Compound 2 (100 mg, 0.38 mmol) was dissolved in MeCN
(2.5 mL) and added to the solution.
The reaction was followed with MALDI-TOF (matrix: dithranol) and the mixture was refluxed
for 22 h under nitrogen. The solvent was evaporated and the yellow oil was dissolved in DCM and
washed with H2O (10 mL × 3) and brine.
After drying over MgSO4, the solvent was evaporated to yield crude compound 5 as a yellow
plastic. The residue was purified by column chromatography (9.5–9:0.5–1 DCM: MeOH) to yield 5
(242 mg, 0.20 mmol, 52%) as a yellow plastic. 1H-NMR (500 MHz, CDCl3): δ 7.12 (bs, Har, 4H), 4.02–2.04
(bs, N-CH2-CO + Hring, 48H), 1.50–1.17 (bs, Ot-Bu, 54H) 13C-NMR (300 MHz, CDCl3): δ 122.24 (Car),
58.81 (Cring) 55.04 (Cring), 28.23 (CtBut), 28.06 (CtBut) ESI+-MS: C62H106N8O16 [M + H]+ m/zcalc 609.38634
m/zfound 609.34983 Melting point: 65.7 ◦C.
3.2.6. Synthesis of Dibenzyl 1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate (6)
Under an inert atmosphere, cyclen (1 g, 5.80 mmol) was dissolved in CHCl3 (52 mL) and
CbzCl (1.69 mL, 11.90 mmol) was added dropwise, resulting in the formation of a white precipitate.
The mixture was heated to 60 ◦C and stirred for 1 h and 40 min. The pH at the end of the reaction was
confirmed to be acidic. The solvent was evaporated under reduced pressure to yield a white solid
mixed with a yellow solid. The solid was washed over a filter with Et2O and the residue was taken up
with 4M aq. NaOH and extracted 4 times with Et2O. The organic layers were washed with 1M aq.
NaOH (×2) and then dried over Na2SO4. The solvent was evaporated under reduced pressure to yield
compound 6 (1.47 g, 3.33 mmol, 57%) as a colourless oil. 1H-NMR (500 MHz, CDCl3): δ 7.36–7.28 (m,
Har, 10H), 5.15 (s, O-CH2-bz), 3.51–3.35 (m, Hring, 8H), 2.99–2.70 (m, Hring, 8H) 13C-NMR (300 MHz,
CDCl3): δ 128.77 (Car), 128.37 (Car), 128.12 (Car), 67.63 (O-C-bz), 51.07 (Cring), 50.66 (Cring), 50.09 (Cring),
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49.52 (Cring), 48.89 (Cring), 48.60 (Cring) ESI+-MS: C38H58N8O16 [M + H]+ m/zcalc 441.24963 m/zfound
441.25100.
3.2.7. Synthesis of Dibenzyl
4,10-bis(2-(tert-Butoxy)-2-Oxoethyl)-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate (7)
Compound 6 (1.47 g, 3.33 mmol) was dissolved in MeCN (24 mL). DIPEA (11.59 mL, 66.55 mmol)
and tert-butyl bromoacetate (0.98 mL, 6.66 mmol) was added. The reaction mixture was refluxed for
30 min. The solvent was evaporated to yield an oil and solid mixture. The oil was taken up with Et2O
and washed with H2O. After drying over Na2SO4, the solvent was evaporated under reduced pressure
to yield a light yellow oil as pure compound 7 (2.21 g, 3.30 mmol, 99%). 1H-NMR (500 MHz, CDCl3):
δ 7.37–7.28 (m, Har, 10H), 5.12 (s, CH2, 4H), 3.52–3.15 (m, CH2, 12H), 2.87 (bs, Hring, 8H), 1.43 (s, Ot-Bu,
18H) 13C-NMR (300 MHz, CDCl3): δ 170.70, 156.62, 137.02 (Car),128.62 (Car), 128.03 (Car), 81.11, 67.14
(O-C-bz), 56.14 (CH2), 54.18 (CH2), 46.72 (Cring), 28.35 (CtBut) ESI+-MS: C38H58N8O16 [M + H]+ m/zcalc
669.38579 m/zfound 669.38769.
3.2.8. Synthesis of Di-tert-butyl 2,2′-(1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetate (8)
To a suspension of Pd/C 10% (442 mg, 20% wt) in iso-propanol (50 mL), a solution of compound 7
(2.21 g, 3.30 mmol) in iso-propanol (30 mL) was added. Ammonium formate (9.57 g, 152 mmol) was
added and the mixture was refluxed for 15 min under constant µwave irradiation (150 W). The catalyst
was filtered off through celite. The solvent was evaporated and the white solid residue was taken
up in 4M aq. NaOH (50 mL) and extracted with CHCl3 (100 mL × 4). The combined organic layers
were dried over Na2SO4 and the solvent evaporated to yield 8 (1.30 g, 98%) as a yellow viscous oil
that became a white solid after a few days’ exposure to air. 1H-NMR (500 MHz, CDCl3): δ 3.31 (s,
OCCH2, 4H), 2.80 (bs, Hring, 8H), 2.61 (t, Hring, 8H), 1.46 (s, Ot-Bu, 18H) 13C-NMR (300 MHz, CDCl3):
δ 171.10, 81.15, 57.35 (CH2), 52.18 (CH2), 45.87 (Cring), 28.36 (CtBut) ESI+-MS: C20H40N4O4 [M + H]+
m/zcalc 401.31223 m/zfound 401.31280.
3.2.9. Synthesis of Di-tert-butyl
2,2′-(4,10-bis(2-(4-((tert-butyldimethylsilyl)oxy)phenoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-
1,7-diyl)diacetate (9)
Compound 8 (350 mg, 0.87 mmol) was dissolved in MeCN (4 mL) and DIPEA (1.52 mL, 8.74 mmol)
was slowly added under a nitrogen atmosphere. After a few minutes, a solution of compound 2 (550 mg,
1.83 mmol) in MeCN (2.2 mL) was added and the mixture was refluxed for 2 h. After this time, the dark
brown mixture was concentrated and the resulting brown oil was dissolved in EtOAc and washed
three times with H2O. After drying over Na2SO4, the solvent was removed under reduced pressure
to yield a brown oil. The residue was purified by column chromatography (9.25:0.75 DCM/MeOH)
to yield compound 9 as a pale yellow oil (451 mg, 0.48 mmol, 55%). 1H-NMR (500 MHz, CDCl3): δ
6.96 (d, Har, 4H), 6.75 (d, Har, 4H), 3.71–2.17 (m-bs, Hring+ N-CH2-CO, 24H), 1.25 (s, Ot-Bu, 18H), 0.98
(s, Si-C-CH3, 18H), 0.19 (s, Si-CH3, 12H) 13C-NMR (300 MHz, CDCl3): δ 173.74, 173.01, 153.50, 144.44,
122.13 (Car), 120.38 (Car), 82.27, 55.86, 55.11, 27.83, 25.78, −4.34 (Si-CH3) ESI+-MS: C48H80N4O10Si2
[M + H]+ m/zcalc 929.54857 m/zfound 929.55713.
3.2.10. Synthesis of
2,2′,2′′-(10-(2-(4-Hydroxyphenoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-Triyl)triacetic
acid (L1)
Compound 4 (100 mg, 0.13 mmol) was dissolved in DCM (0.32 mL) and TFA (0.22 mL, 3.47 mmol)
was slowly added to the mixture. The reaction was followed with MALDI-TOF (matrix: dithranol)
until the starting material could no longer be observed. The clear solution was stirred at room
temperature for 2 days, after which it was concentrated under reduced pressure. The resulting brown
oil was dissolved in the minimum amount of MeOH and triturated multiple times with Et2O to yield
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compound L1 (25 mg, 0.12 mmol, 39%) as a white powder. 1H-NMR (500 MHz, MeOD): δ 7.02 (d, Har,
2H), 6.77 (d, Har, 2H), 4.01 (s, N-CH2-CO, 2H), 3.81 (s, N-CH2-CO, 4H), 3.62–2.47 (m, N-CH2-CO + Hring,
8H), 3.19–3.11 (m, Hring, 8H) 13C-NMR (300 MHz, MeOD): δ 144.47 (C4), 123.43 (Car), 116.52 (Car),
57.58, 54.27, 52.51 ESI+-MS: C22H32N4O9 [M + H]+ m/zcalc 497.22421 m/zfound 497.22337 Melting point:
175.2 ◦C.
3.2.11. Synthesis of 10-(1,4-Phenylene) bis-1,4,7,10-tetraazacyclododecane-1,4,7-Triyl)acetate (L2)
Compound 5 (200 mg, 0.16 mmol) was dissolved in DCM (0.3 mL) and TFA (0.37 mL, 5.74 mmol)
was added dropwise. The clear solution was stirred at room temperature for two days. After this time
the solvent was evaporated and the resulting brown oil was dissolved in the minimum amount of
MeOH and triturated with Et2O to yield compound L2 (47 mg, 0.05 mmol, 32%) as a white powder.
1H-NMR (500 MHz, D2O): δ 7.28–6.93 (m, Har, 4H), 4.04–3.08 (m, N-CH2-CO + Hring, 48H) 13C-NMR
(300 MHz, D2O): δ 122.67 (Car), 51.37 (Cring), 48.01 (Cring) ESI+-MS: C38H58N8O16 [M + H]+ m/zcalc
442.20581 m/zfound 442.20612 Melting point: 216.7 ◦C.
3.2.12. Synthesis of
2,2′-(4,10-Bis(2-(4-hydroxyphenoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic
Acid (L3)
Compound 9 (326 mg, 0.35 mmol) was dissolved in DCM (0.17 mL) and TFA (0.80 mL, 12.28 mmol)
was slowly added to the mixture. The clear solution was stirred at room temperature for 3 days. After
this time, it was concentrated under reduced pressure. The brown oil was dissolved in a minimum
amount of MeOH and triturated multiple times with Et2O to yield compound L3 (75 mg, 0.13 mmol,
36%) as an off-white powder. 1H-NMR (500 MHz, D2O): δ 7.00 (d, Har, 4H), 6.87 (d, Har,4H), 3.96 (s,
N-CH2-CO, 4H), 3.91 (s, N-CH2-CO, 4H), 3.60 (s, Hring, 4H), 3.53 (s, Hring, 4H), 3.20 (s, Hring, 4H), 3.15
(s, Hring, 4H) 13C-NMR (300 MHz, D2O): δ 122.56 (Car), 116.01 (Car), 51.36, 47.91 ESI+-MS: C22H32N4O9
[M + H]+ m/zcalc 589.25042 m/zfound 589.24967 Melting point: 214.1 ◦C.
3.3. Synthesis of the Complexes
The ligand Ln (1 eq) was dissolved in MeOH and Ln(OTf)3 (1 eq for n = 1, 3; 2 eq for n = 2) was
added to the solution. The reaction mixture was stirred at 60 ◦C for 48–72 h. After this time, the solvent
was evaporated and the residue was dissolved in a minimal amount of MeOH and precipitated with
diethyl ether to yield a white powder. The complexes were dried by the freeze-dry method, stored in
sealed vials under argon and dried again at the oil pump before every use.
3.3.1. Eu.L1
1H-NMR (500 MHz, D2O): δ 33.37 (s, Ha-ax), 32.99 (s, Ha-ax), 26.63 (s, Ha-ax), 24.73 (s, Ha-ax), 11.84 (s,
Ha-ax), 7.58 (s), −0.50 (s), −0.83 (s), −1.17 (s), −3.54 (s), −5.40 (s), −6.45 (s), −6.85 (s), −7.92 (s), −8.97
(s), −9.57 (s), -10.48 (s), −12.40 (s), −14.14 (s), −14.45 (s), −15.67 (s), −16.71 (s), −18.98 (s). ESI+-MS:
C22H30EuN4O9 [M-BQ + Li + Na]+ m/zcalc: 581.0859; m/zfound: 581.12683.
3.3.2. Eu.L2
1H-NMR (500 MHz, D2O): δ 33.45 (s, Ha-ax), 33.04 (s, Ha-ax), 26.57 (s, Ha-ax), 24.68 (s, Ha-ax), 13.16 (s,
Ha-ax), −0.55 (s), −0.85 (s), −1.13 (s, Ha-eq), −2.00 (s), −3.52 (s), −4.19 (s), −5.36 (s), −6.38 (s), −6.77 (s,
Hb-eq), −7.30 (s), −7.94 (s, Hb-ax), −8.77 (s), −8.95 (s), −9.57 (s), −10.36 (s), −12.35 (s), −14.09 (s), −14.47
(s, Hc), −15.72 (s, Hc’), −16.72 (s), −18.99 (s). ESI+-MS: C38H54Eu2N8O16 [M-Eu.L1 + 2H]2+ m/zcalc:
553.09497; m/zfound: 553.09433.
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3.3.3. Eu.L3
1H-NMR (500 MHz, D2O): δ 32.81 (s, Ha-ax), 26.48 (s, Ha-ax), 24.55 (s, Ha-ax), 12.58 (s, Ha-ax), −0.50 (s),
−1.26 (s, Ha-eq), −4.07 (s), −5.33 (s), −6.87 (s, Hb-eq), −7.68 (s, Hb-ax), −8.88 (s), −9.63 (s), −10.37 (s), −12.28
(s), −14.28 (s, Hc), −15.28 (s, Hc’), −16.71 (s), −18.93 (s). ESI+-MS: C28H35EuN4O10 [M-2BQ + Li + Na]+
m/zcalc: 740.15600; m/zfound: 581.0859.
3.3.4. Tb.L1
1H-NMR (500 MHz, D2O): δ 158.10 (s), 141.43 (s), 82.28 (s), −15.97 (s), −21.11 (s), −27.08 (s), −45.67 (s),
−65.83 (s), −89.49 (s), −94.24 (s), −98.91 (s), −114.70 (s), −155.75 (s), −184.30 (s), −307.81 (s), −334.80 (s).
ESI+-MS: C22H30TbN4O9 [M-BQ + Li + Na]+ m/zcalc: 589.09059; m/zfound 589.13109.
3.3.5. Tb.L2
1H-NMR (500 MHz, D2O): δ 259.21 (s), 136.45 (s), 82.55 (s), −15.86 (s), −26.89 (s), −37.37 (s), −41.28 (s),
−45.65 (s), −65.68 (s), −65.90 (s), −95.32 (s), −98.89 (s), −114.68 (s), −155.90 (s), −184.35 (s), −227.85 (s),
−388.21 (s). ESI+-MS: C38H54Tb2N8O16 [M-Tb.L1 + 2H]2+ m/zcalc: 561.10046; m/zfound: 561.09983.
3.3.6. Tb.L3
1H-NMR (500 MHz, D2O): δ 257.88 (s), 157.74 (s), 141.11 (s), 135.48 (s), 82.26 (s), −15.81 (s), −27.23 (s),
−37.31 (s), −41.46 (s), −45.59 (s), −65.80 (s), −95.02 (s), −98.57 (s), −114.58 (s), −155.58 (s), −184.08 (s).
ESI+-MS: C28H35TbN4O10 [M-2BQ + 2H]+ m/zcalc: 561.10046; m/zfound 561.09930.
3.4. Oxidation Tests
In a typical experiment, hydroquinone or alpha-tocopherol were dissolved in the solvent (HEPES
0.1M pH 7.2 + 1% Triton X-100) to concentration 0.04 M in a small vial. When HEPES buffer was
employed, hydroquinone was first dissolved in the smallest amount of EtOH possible and HEPES
buffer with 1% Triton X-100 was added. If necessary, the mixture was sonicated in a water bath to
favour solubilisation. The test compound (hydroquinone or α-tocopherol) was added to the mixture
at room temperature and stirred for 5 min before withdrawal of a sample and dilution to 0.1 mM in
a volumetric flask and transfer of 3 mL of sample in a cuvette. The absorption measurements were
acquired scanning the wavelength range 800–200 nm.
The complex was dissolved in HEPES buffer 0.1 M at pH 7.2 to concentration 0.04 M. 75 µL
of solution were withdrawn, transferred in a cuvette and brought to volume (3 mL) by addition of
2.925 mL of H2O to have a resulting 1mM concentration. HOCl (from HOCl 5% w/v up to 25 equivalents
for Eu.L1, 38 equivalents for Eu.L2, 28 equivalents for Eu.L3, 20 equivalents for Tb.L1, 22 equivalents
for Tb.L2, 28 equivalents for Tb.L3) was added to the mixture at room temperature and the cuvette was
intermittently shaken for 5 min. After this time, the measurements were obtained.
4. Conclusions
Mono-and diesters of hydroquinone were synthesised and coupled to cyclen-based carboxylate
ligands. Three different ligands L1, L2, and L3 were prepared and used to form europium(III) and
terbium(III) complexes: Ln.L1, Ln.L2, and Ln.L3. In total, six new complexes of europium(III) and
terbium(III) were synthesized, characterised and tested for their activity towards the HOCl using a
testbed developed in order to give reproducible results when exploring oxidation reactions. The testbed
is based on a HEPES buffer at pH 7.2, with Triton-X added to ensure solubility of lipophilic systems.
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The complexes Ln.L1 and Ln.L2 were found to behave as DOTA-monoamide complexes, despite
being mono-esters. NMR and luminescence spectra showed that Ln.L1 is more flexible than diester Ln.L2.
Ln.L3 is a DOTA-diester, and the added steric bulk resulted in a more rigid structure. All investigated
complexes reacted selectively with HOCl. The reaction resulted in that the esters were hydrolysed,
converting all complexes via one or two steps to [Ln.DOTA]−. The conversion could be followed
using luminescence spectroscopy with a direct intensity-based or a ratiometric readout. Independent
of the stoichiometry of the reaction, in exceed of 15 equivalents were needed to fully convert the
probes to [Ln.DOTA]−. Thus, we conclude that incorporating the hydroquinone unit in a lanthanide
complex reduces the reactivity towards reactive oxygen species. Additionally, the reactivity of the
hydroquinone esters is dictated by the structure of the lanthanide complex, as exemplified by the
activity of the di-ester in Ln.L2 and mono-esters in Ln.L3. The next step is to incorporate an efficient
antenna and a hydroquinone caging unit in a single lanthanide(III) complex.
Supplementary Materials: The following are available online, NMR spectra, mass spectra, absorption spectra,
time-resolved emission profiles, and luminescence spectra.
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